Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial

2020159 citationsJournal Articlehybrid Open Access

Authors

Douglas K. Rex · Indiana University School of Medicine

Raj Bhandari · Delta Air Lines (United States)

Daniel Lorch · Pulmonary Associates

Michael O. Meyers · Paion (United Kingdom)

Frank Schippers · Paion (Germany)

David Bernstein · Hofstra University

Abstract

Remimazolam is safe and efficient in procedural sedation of high risk ASA patients undergoing colonoscopy, showing a safety profile comparable to that in low risk ASA.

Topics & Keywords

Anesthesia and Sedative Agents Intensive Care Unit Cognitive Disorders Nausea and vomiting management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Digestive and Liver Disease

Volume 53, Issue 1, pp. 94-101

DOI: 10.1016/j.dld.2020.10.039

Field-Weighted Citation Impact: 15.29